Assessment and Treatment of Depression and Anxiety: Integrating Psychopharmacology and psychotherapy 2021

Assessment and Treatment of Depression and Anxiety: Integrating Psychopharmacology and psychotherapy 2021

Regular price
$25.00
Sale price
$25.00
Regular price
Sold out
Unit price
per 

5 videos


Learn Now: Advances in Psychopharmacology and Psychotherapy


In addition to highlighting emerging strategies in the assessment and treatment of major depression and bipolar illness, this online CME course defines approaches to mood and anxiety disorders, including psychodynamic psychotherapy, cognitive and behavioral therapy, interpersonal psychotherapy for depression and other psychotherapeutic approaches.


Assessment and Treatment of Depression and Anxiety: Integrating Psychopharmacology and Psychotherapy also addresses comorbid conditions such as Axis II personality disorders, management of patients with medical conditions, management of the geriatric patient, and more. It’s psychiatry CME that offers insight into:



  • Issues around the choice of specific antidepressants, mood stabilizers and anti-anxiety medications

  • Psychopharmacologic management of the treatment resistant patient

  • Recent developments in neuropsychiatry, including brain imaging and therapeutic stimulation techniques

  • Therapeutic efficacy and risks associated with ketamine administration

  • Obsessive-compulsive disorders including skin-picking, trichotillomania and body dysmorphic

  • Management of anxiety in patients vulnerable to abuse of alcohol

  • And more…




Topics/Speakers


All lectures by Russell G. Vasile, MD


Assessment and Treatment of Major Depressive Disorder


Psychopharmacologic Management of Bipolar Disorder Emerging Perspectives


Anxiety Disorders- Assessment and Pharmacotherapy


Suicide Assessment and Prevention, Psychotherapy of Depression and Perspectives on Personality Disorder


Assessment and Management of Depression in the Elderly and Brain Imaging